Ejegod, D. M., Lagheden, C., Bhatia, R., Pedersen, H., Boada, E. A., Sundström, K., . . . Bonde, J. (2020). Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening. BMC cancer, 20(1), 396-13. https://doi.org/10.1186/s12885-020-06888-0
Citácia podle Chicago (17th ed.)Ejegod, Ditte Møller, et al. "Clinical Validation of Full Genotyping CLART® HPV4S Assay on SurePath and ThinPrep Collected Screening Samples According to the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening." BMC Cancer 20, no. 1 (2020): 396-13. https://doi.org/10.1186/s12885-020-06888-0.
Citácia podľa MLA (8th ed.)Ejegod, Ditte Møller, et al. "Clinical Validation of Full Genotyping CLART® HPV4S Assay on SurePath and ThinPrep Collected Screening Samples According to the International Guidelines for Human Papillomavirus Test Requirements for Cervical Screening." BMC Cancer, vol. 20, no. 1, 2020, pp. 396-13, https://doi.org/10.1186/s12885-020-06888-0.